|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
|
EP1142889A1
(en)
|
2000-04-03 |
2001-10-10 |
Pfizer Products Inc. |
Pyrazole derivatives as anti-inflammatory/analgesic agents
|
|
US7435755B2
(en)
|
2000-11-28 |
2008-10-14 |
The Trustees Of Dartmouth College |
CDDO-compounds and combination therapies thereof
|
|
CA2430454A1
(en)
|
2000-11-28 |
2002-06-20 |
Board Of Regents, The University Of Texas System |
Cddo-compounds and combination therapies thereof
|
|
JP2005507892A
(ja)
|
2001-09-19 |
2005-03-24 |
ファルマシア・コーポレーション |
炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物
|
|
DK1465615T3
(da)
|
2002-01-15 |
2012-11-12 |
Dartmouth College |
Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
|
|
AU2003303128A1
(en)
|
2002-05-13 |
2004-08-13 |
Trustees Of Dartmouth College |
Inhibitors and methods of use thereof
|
|
EP2298315A1
(en)
*
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Therapeutic treatment methods
|
|
WO2006089406A1
(en)
|
2005-02-22 |
2006-08-31 |
Gemin X Biotechnologies Inc. |
Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
|
|
US8921340B2
(en)
|
2006-11-17 |
2014-12-30 |
Trustees Of Dartmouth College |
Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
|
|
US7714012B2
(en)
|
2006-11-17 |
2010-05-11 |
Trustees Of Dartmouth University |
Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
|
|
US8299046B2
(en)
|
2006-11-17 |
2012-10-30 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
|
|
WO2008136838A1
(en)
|
2007-05-04 |
2008-11-13 |
Trustees Of Dartmouth College |
Novel amide derivatives of cddo and methods of use thereof
|
|
US20090048205A1
(en)
|
2007-08-15 |
2009-02-19 |
Colin Meyer |
Combination therapy with synthetic triterpenoids and gemcitabine
|
|
US8088824B2
(en)
|
2007-08-15 |
2012-01-03 |
Reata Pharmaceuticals Inc. |
Forms of CDDO methyl ester
|
|
PL2252283T3
(pl)
|
2008-01-11 |
2019-09-30 |
Reata Pharmaceuticals, Inc. |
Syntetyczne triterpenoidy i sposoby zastosowania w leczeniu choroby
|
|
WO2009146216A2
(en)
|
2008-04-18 |
2009-12-03 |
Reata Pharmaceuticals. Inc. |
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
|
|
CN102164941B
(zh)
|
2008-04-18 |
2015-05-27 |
里亚塔医药公司 |
抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
|
|
CA2721665C
(en)
|
2008-04-18 |
2017-01-24 |
Reata Pharmaceuticals, Inc. |
Compounds including an anti-inflammatory pharmacore and methods of use
|
|
RS55631B1
(sr)
|
2008-04-18 |
2017-06-30 |
Reata Pharmaceuticals Inc |
Antioksidansni modulatori upale: c-17 homologisani derivati oleanolinske kiseline
|
|
WO2009129546A1
(en)
|
2008-04-18 |
2009-10-22 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
|
|
US8278311B2
(en)
|
2008-04-28 |
2012-10-02 |
Abbott Laboratories |
Substituted pyrimidine derivatives
|
|
ES2449396T3
(es)
|
2008-07-22 |
2014-03-19 |
Trustees Of Dartmouth College |
Cianoenonas monocíclicas y métodos de uso de las mismas
|
|
WO2010053817A1
(en)
|
2008-11-04 |
2010-05-14 |
Trustees Of Dartmouth College |
Betulinic acid derivatives and methods of use thereof
|
|
SMT201900432T1
(it)
|
2009-02-13 |
2019-09-09 |
Reata Pharmaceuticals Inc |
Composizioni di dosaggio orali, a rilascio ritardato contenenti cddo-me amorfo
|
|
MX357596B
(es)
|
2010-04-12 |
2018-07-16 |
Reata Pharmaceuticals Inc |
Método para tratar obesidad utilizando moduladores de inflamación con antioxidantes.
|
|
PL2651902T3
(pl)
|
2010-12-17 |
2018-04-30 |
Reata Pharmaceuticals, Inc. |
Pirazolilowe i pirymidynylowe tricykliczne enony jako modulatory zapalenia o działaniu przeciwutleniającym
|
|
SI2683731T1
(sl)
|
2011-03-11 |
2019-07-31 |
Reata Pharmaceuticals, Inc. |
C4-monometil triterpenoidni derivati in postopki njihove uporabe
|
|
JP6410710B2
(ja)
|
2012-04-27 |
2018-10-24 |
リアタ ファーマシューティカルズ インコーポレイテッド |
バルドキソロンメチルの２，２−ジフルオロプロピオンアミド誘導体、その多形体および使用方法
|
|
WO2013188818A1
(en)
|
2012-06-15 |
2013-12-19 |
Reata Pharmaceuticals, Inc. |
A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
|
|
US9278912B2
(en)
|
2012-09-10 |
2016-03-08 |
Reata Pharmaceuticals, Inc. |
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
|
|
US9512094B2
(en)
|
2012-09-10 |
2016-12-06 |
Reata Pharmaceuticals, Inc. |
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
|
|
WO2014040060A1
(en)
|
2012-09-10 |
2014-03-13 |
Reata Pharmaceuticals, Inc. |
C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
|
|
US20140088163A1
(en)
|
2012-09-10 |
2014-03-27 |
Reata Pharmaceuticals, Inc. |
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
|
|
BR112016003454B1
(pt)
|
2013-08-23 |
2023-02-14 |
Reata Pharmaceuticals, Inc. |
Uso de composto de metil bardoxolona
|
|
JP6530758B2
(ja)
|
2014-01-24 |
2019-06-12 |
リアタ ファーマシューティカルズ，インク |
抗酸化性炎症調節剤としてのアリールおよびアリールアルキル置換されたピラゾリルおよびピリミジニル三環式エノン類
|
|
EP3256450B1
(en)
|
2015-02-11 |
2020-12-02 |
Merck Sharp & Dohme Corp. |
Substituted pyrazole compounds as ror-gamma-t inhibitors and uses thereof
|
|
CN107428698B
(zh)
*
|
2015-02-12 |
2021-10-26 |
里亚塔医药公司 |
作为抗氧化炎症调节剂的咪唑基三环烯酮
|
|
KR102114536B1
(ko)
|
2015-05-07 |
2020-05-22 |
브리스톨-마이어스 스큅 컴퍼니 |
RORγ 조정제로서의 트리시클릭 술폰
|
|
TWI735681B
(zh)
|
2016-10-24 |
2021-08-11 |
瑞典商阿斯特捷利康公司 |
化合物
|
|
TWI831738B
(zh)
|
2016-12-16 |
2024-02-11 |
美商瑞塔醫藥有限責任公司 |
用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
|
|
LT3555097T
(lt)
|
2016-12-16 |
2022-08-25 |
Janssen Pharmaceutica Nv |
Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai
|
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
|
CA3045224A1
(en)
|
2016-12-16 |
2018-06-21 |
Basf Se |
Pesticidal compounds
|
|
EP3555064B9
(en)
|
2016-12-16 |
2023-03-01 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
WO2019246461A1
(en)
|
2018-06-20 |
2019-12-26 |
Reata Pharmaceuticals, Inc. |
Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
|